<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Polymerase chain reaction (PCR) was used to amplify the DNA fragments of the complementarity determining region 3 of the immunoglobulin (Ig) gene heavy chain from the leukemic cell specimens of patients with <z:hpo ids='HP_0011009'>acute</z:hpo> and <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0005526'>lymphoid leukemias</z:hpo> of B-cell lineage </plain></SENT>
<SENT sid="1" pm="."><plain>Two different pairs of primers were tested </plain></SENT>
<SENT sid="2" pm="."><plain>Fourteen of the 17 (82%) cases of <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (ALL), and <z:hpo ids='HP_0000001'>all</z:hpo> 15 cases (100%) of B-cell <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo>, who had rearrangement of the Ig gene heavy chain by Southern analysis, were positive by PCR with either one or both pairs of primers </plain></SENT>
<SENT sid="3" pm="."><plain>This technique was able to detect leukemic cells at the level of 0.1% </plain></SENT>
<SENT sid="4" pm="."><plain>Applying it to study the remission marrow specimens following induction chemotherapy was more useful than <z:mp ids='MP_0000002'>morphology</z:mp> alone in predicting early relapse of the <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
</text></document>